Effect of ladasten on proliferative activity and apoptosis in peripheral blood T-lymphocytes ]
Lab research · 2002
- What was studied
- Activated human peripheral-blood T lymphocytes in culture
- Main finding
- Studies proliferation and resistance to chemically induced apoptosis in cultured T cells.
Comitogenic concentration range · 0.01–1 microM as printed
Reported findings and study design
Activated human T-cell cultures for 72 hours; Ladasten tested over 0.1–10 microM, with a separately stated comitogenic range of 0.01–1 microM.
Population or model Activated human peripheral-blood T lymphocytes in culture
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Comitogenic concentration range | 0.01–1 microM as printed | |
| Caspase-3/late apoptosis/bcl-2 | Unchanged | |
| p53 and induced-apoptosis resistance | Changes reported | No numerical expression or surviving-cell fraction supplied |
The two printed concentration ranges are retained separately rather than silently reconciled.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Human-derived cells are not a clinical trial; culture concentrations do not establish therapeutic exposure or immune benefit.
Source details
Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.
Sources checked
Citation
Vakhitova IuV, Sibiriak SV, Kurchatova NN, Seredenin SB. Effect of ladasten on proliferative activity and apoptosis in peripheral blood T-lymphocytes ] Eksperimental'naia i klinicheskaia farmakologiia 65(6):49-52. PMID 12596534